Atlas FDA

EluNIR Ridaforolimus Eluting Coronary Stent System

FDA premarket approval P170008/S031 · decided 2020-12-21

Approval details

PMA number
P170008
Supplement
S031
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
EluNIR Ridaforolimus Eluting Coronary Stent System
Generic name
Coronary drug-eluting stent
Applicant
Medinol, Ltd.
Date received
2020-11-23
Decision date
2020-12-21
Days to decision
28 days
Decision code
OK30
Product code
NIQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Tel Aviv
Statement
a change to EluNIR’s sterilization process for the verification of successful sterilization

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Gallant PTCA Dilatation Catheter (K173581)Medinol, Ltd.2018-01-25
NC Gallant PTCA Catheter (K162434)Medinol, Ltd.2017-01-19
X-Suit NIR Biliary Metallic Stent (K150487)Medinol, Ltd.2016-02-12
MEDINOL X-SUIT NIR BILIARY METALLIC STENT (K081956)Medinol, Ltd.2009-01-09
NIR BILIARY STENT (K002130)Medinol, Ltd.2000-10-30
NIR BILIARY STENT (K973171)Medinol, Ltd.1998-11-13